Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours. (2019)

First Author: McDaid WJ
Attributed to:  The Queen’s University of Belfast Confidence in Concept programme 2016 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/c9nr07257h

PubMed Identifier: 31626255

Publication URI: http://europepmc.org/abstract/MED/31626255

Type: Journal Article/Review

Volume: 11

Parent Publication: Nanoscale

Issue: 42

ISSN: 2040-3364